Cancer-associated fibroblasts, macrophages, T cells, and other accessory cells present in the tumor microenvironment are also known to modulate expression of the NKG2D receptor and production of interferon gamma (IFNγ) in NK cells (Vitale et al., 2014). The gene discussed is IFNG; the disease is cancer.